Garen G. Bohlin

Director, ACUSPHERE INC.

Companies

COLLEGIUM PHARMACEUTICAL, INCBoard member May 6, 2015 to now¹
Karyopharm Therapeutics Inc.Board member Nov 5, 2013 to now²
Tetraphase Pharmaceuticals (United States)Board member Mar 19, 2013 to Jun 11, 2019³
Proteon TherapeuticsBoard member Oct 21, 2014 to Jun 11, 2018⁴
Targanta Therapeutics CorporationBoard member Oct 10, 2007 to Jun 3, 2008⁵

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

May 21, 2026Granted 15,508 shares of Karyopharm Therapeutics Inc.⁷
May 14, 2026Granted 8,741 shares of COLLEGIUM PHARMACEUTICAL, INC⁶
May 11, 2026Sold 8,700 shares at $37.18 of COLLEGIUM PHARMACEUTICAL, INC⁸
May 11, 2026Exercised options 8,700 shares at $16.49 of COLLEGIUM PHARMACEUTICAL, INC⁸
May 15, 2025Granted 9,791 shares of COLLEGIUM PHARMACEUTICAL, INC⁹
May 16, 2024Granted 7,693 shares of COLLEGIUM PHARMACEUTICAL, INC¹⁰
May 14, 2024Sold 28,985 shares at $32.30 of COLLEGIUM PHARMACEUTICAL, INC¹⁰
May 14, 2024Exercised options 28,985 shares at $5.73 of COLLEGIUM PHARMACEUTICAL, INC¹⁰
Sep 12, 2023Bought 41,140 shares at $1.22 of Karyopharm Therapeutics Inc.¹¹
May 18, 2023Granted 9,792 shares of COLLEGIUM PHARMACEUTICAL, INC¹²
May 19, 2022Granted 14,035 shares of COLLEGIUM PHARMACEUTICAL, INC¹³

The numbers on this page point here. Each one links to the record it came from.